The new anticonvulsant retigabine (D-23129) acts as an opener of K + channels in neuronal cells

Author： Rundfeldt C.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.336, Iss.2, 1997-10, pp. : 243-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures

By Tober C.   Rostock A.   Rundfeldt C.   Bartsch R.  

European Journal of Pharmacology, Vol. 303, Iss. 3, 1996-05 ,pp. : 163-169

Elsevier

Access to resources Recommend Favorite

Retigabine/Ezogabine, a KCNQ/KV7 channel opener: pharmacological and clinical data

By Orhan Gökce   Wuttke Thomas V   Nies Anne T   Schwab Matthias   Lerche Holger  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 12, 2012-08 ,pp. : 1807-1816

Informa Healthcare

Access to resources Recommend Favorite

The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain

By Blackburn-Munro G.   Jensen B.S.  

European Journal of Pharmacology, Vol. 460, Iss. 2, 2003-01 ,pp. : 109-116

Elsevier

Access to resources Recommend Favorite

Differential blockade of neuronal voltage-gated Na + and K + channels by antidepressant drugs

By Nicholson G.M.   Blanche T.   Mansfield K.   Tran Y.  

European Journal of Pharmacology, Vol. 452, Iss. 1, 2002-09 ,pp. : 35-48

Elsevier

Access to resources Recommend Favorite

A role for neuronal K ATP channels in metabolic control of the seizure gate

By Yamada K.   Inagaki N.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 12, 2001-12 ,pp. : 601-602

Elsevier

Access to resources Recommend Favorite